Rossing P - Search Results

1

Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials.

Rossing P, Inzucchi SE, Vart P, Jongs N, Docherty KF, Jhund PS, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Solomon SD, DeMets DL, Bengtsson O, Lindberg M, Langkilde AM, Sjöstrand M, Stefansson BV, Karlsson C, Chertow GM, Hou FF, Correa-Rotter R, Toto RD, Wheeler DC, McMurray JJV, Heerspink HJL; DAPA-CKD and DAPA-HF Trial Committees and Investigators. Rossing P, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):24-34. doi: 10.1016/S2213-8587(21)00295-3. Epub 2021 Nov 29. Lancet Diabetes Endocrinol. 2022. PMID: 34856173 Free article.

2

Low birth weight. A risk factor for development of diabetic nephropathy?

Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving HH. Rossing P, et al. Diabetes. 1995 Dec;44(12):1405-7. doi: 10.2337/diab.44.12.1405. Diabetes. 1995. PMID: 7589846

3

Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.

Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes. 1995 May;44(5):489-94. doi: 10.2337/diab.44.5.489. Diabetes. 1995. PMID: 7729604

4

Unchanged incidence of diabetic nephropathy in IDDM patients.

Rossing P, Rossing K, Jacobsen P, Parving HH. Rossing P, et al. Among authors: rossing k. Diabetes. 1995 Jul;44(7):739-43. doi: 10.2337/diab.44.7.739. Diabetes. 1995. PMID: 7789641

5

On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy.

Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1995 Jul;44(7):783-9. doi: 10.2337/diab.44.7.783. Diabetes. 1995. PMID: 7789646

6

Prevalence of arterial hypertension in diabetic patients before and after the JNC-V.

Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes Care. 1994 Nov;17(11):1247-51. doi: 10.2337/diacare.17.11.1247. Diabetes Care. 1994. PMID: 7821162

7

Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1994 Sep;43(9):1108-13. doi: 10.2337/diab.43.9.1108. Diabetes. 1994. PMID: 8070610 Clinical Trial.

8

Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH. Rossing P, et al. Diabetes. 1997 Mar;46(3):481-7. doi: 10.2337/diab.46.3.481. Diabetes. 1997. PMID: 9032106 Clinical Trial.

9

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1997 Jul;46(7):1182-8. doi: 10.2337/diab.46.7.1182. Diabetes. 1997. PMID: 9200654 Clinical Trial.

10

Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.

Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, Parving HH. Rossing K, et al. Among authors: rossing p. Diabetes Care. 1998 Nov;21(11):2007-15. doi: 10.2337/diacare.21.11.2007. Diabetes Care. 1998. PMID: 9802759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters